High Cross-site scripting

CVE-2025-36126 — IBM Cognos Analytics is affected by Cross-site scripting.

IBM Cognos Analytics 11.2.0, 12.0, and 12.1.0 and IBM Cognos Transformer 12.0, 11.2.4, and 12.1.0 is vulnerable to stored cross-site scripting (XSS) in Cognos Adminstration. This vulnerability allows a privileged user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.

Published May 26, 2026 · Updated Oct 13, 2026 · Sources: NIST National Vulnerability Database, CVE Program (cve.org) e CISA ADP · CNA: ibm

Low

Who exploits it and how urgent it is

A 0–100 score combining confirmed exploitation, ransomware and APT use, public exploits, EPSS and severity.

No exploitation signal in the sources consulted so far.

How the score was calculated

EPSS 0.2% (30-day exploitation probability)+1
Technical severity (high)+6

The score orders the patch queue; it does not replace your asset context (internet exposure, criticality, compensating controls).

Triage

Is it exploited, how likely is exploitation, what does it touch, and how severe do the sources call it.

Exploitation

Not confirmed

Not in CISA KEV — an absence of record, not proof it is unexploited.

EPSS FIRST

0.19%

ahead of 8% of scored CVEs · Oct 15, 2026

Affects

Ibm

Cognos Analytics and 1 more

CVSS base

7.6

High · 3 source(s)

CISA SSVC assessment CISA

Three decision points CISA publishes for the CVEs it assesses (SSVC 2.0.3). A stakeholder decision, not a severity score.

Exploitation

None

none · proof-of-concept · active

Automatable

can an attacker script the kill-chain steps

Technical impact

Partial

partial · total control of the vulnerable component

Remediation

Fixes and mitigations documented by the sources — linked to the original advisory.

No fix documented by the sources we poll. That does not mean none exists: check the vendor advisory.

First 24 hours

Ordered from the record’s own fields — exposure first, because you cannot patch what you have not found. A rule-generated starting point.

Identify exposed assets running the affected vendor/product/version combinations (Ibm Cognos Analytics, Ibm Cognos Transformer).
No fix documented in the sources: reduce exposure and monitor the vendor advisory.
Exploitation requires user interaction: tighten email/web filtering and warn affected users.
Search available logs for exploit probes matching the vulnerability class (cross-site scripting), errors and authentication anomalies.

Affected scope

Vendor, product and versions as the sources word them.

Vendor	Product	Versions	Status	Source
Ibm	Cognos Analytics	version 11.2version 12.0.4-interim_fix_3version 12.0.4-interim_fix_2version 12.0.4-interim_fix_1version 12.0.4-fixpack1version 12.0.4version 12.0.3-interim_fix_2version 12.0.3-interim_fix_1 and 21 more version 12.0.3version 12.0.2version 12.0.1version 12.0.0version 11.2.4-interim_fix_5version 11.2.4-interim_fix_3≥ 12.1.0 and < 12.1.2version 11.2.0version 11.2.1version 11.2.2version 11.2.3version 11.2.4version 11.2.4-fixpack1version 11.2.4-fixpack2version 11.2.4-fixpack3version 11.2.4-fixpack4version 11.2.4-fixpack5version 11.2.4-fixpack6version 11.2.4-interim_fix_1version 11.2.4-interim_fix_2version 11.2.4-interim_fix_4	Vulnerable	NIST National Vulnerability Database
Ibm	Cognos Analytics	version 12.1.0version 12.0version 11.2.0	Vulnerable	CVE Program (cve.org) e CISA ADP
Ibm	Cognos Transformer	version 11.2.4version 12.0version 12.1.0	Vulnerable	NIST National Vulnerability Database
Ibm	Cognos Transformer	version 12.0version 11.2.4version 12.1.0	Vulnerable	CVE Program (cve.org) e CISA ADP

Attack characteristics

The CVSS vector, decoded. It describes the attack, not your exposure to it.

Attack vector

Network

Attack complexity

Low

Privileges required

Low

User interaction

Required

Scope

Changed

Confidentiality

High

Integrity

Low

Availability

None

Every base score collected

Sources score independently and may disagree; each row says who scored it and under which version.

Score	Version	Severity	Expl.	Impact	Scored by
7.6	CVSS 3.1	High	2.3	4.7	nvd@nist.gov via NIST National Vulnerability Database
6.4	CVSS 3.1	Medium	3.1	2.7	psirt@us.ibm.com via NIST National Vulnerability Database
6.4	CVSS 3.1	Medium	—	—	ibm via CVE Program (cve.org) e CISA ADP

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:H/I:L/A:N (score shown at the top: nvd@nist.gov)

Scoring entities (NIST, CNA, ADP) score independently; each score is shown with its origin. For prioritization we use 7.6 (NVD (NIST)) as a conservative provisional reference — not a definitive official score.

Weakness MITRE

Weakness class according to MITRE’s CWE catalog.

CWE-79 · Cross-site Scripting (XSS)

Other CVEs with this weakness →

EPSS over time FIRST

Oct 13, 2026 → Oct 15, 2026 · 3 reading(s) · max 0.19%

Detection

Read off the CVSS vector and the weakness class. Starting points, not tested rules.

Prioritize edge telemetry for the network-reachable component (proxy, WAF, IDS/IPS).
Monitor CSP violation reports and script payloads in reflected parameters.

web/proxy/WAF logsnetwork IDS/IPSapplication logs

Timeline

What happened to this CVE, newest first.

2026
Affected products added · ibm/cognos analytics, ibm/cognos transformer
Oct 13, 2026 · CVE Program (cve.org) e CISA ADP
SSVC assessment updated
Oct 13, 2026 · CVE Program (cve.org) e CISA ADP
Record published
Oct 13, 2026
CVSS changed · 7.6
Oct 13, 2026 · NIST National Vulnerability Database
Source status changed · → Analyzed
Oct 13, 2026 · NIST National Vulnerability Database
Record created in this database
Oct 13, 2026 · NIST National Vulnerability Database
CVE published
May 26, 2026 · ibm

Source activity

Repeated readings are counted rather than listed.

1× Official description updated · Oct 13, 2026 – Oct 13, 2026

References

1 on the record

www.ibm.com/support/pages/node/7272628
Vendor Advisory, vendor-advisory, patch, NIST National Vulnerability Database

Elsewhere on this site

Ibm
every CVE for this vendor

Cross-site scripting
same class

CWE-79
other pages naming this weakness

Related CVEs (same products)

Medium CVE-2025-33147 IBM Cognos Analytics versions 12.0.4 and 12.1.3 is affected by security vulnerabilities 27d
Medium CVE-2025-36076 IBM Cognos Analytics versions 12.0.4 and 12.1.3 is affected by security vulnerabilities 27d
Medium CVE-2024-56344 IBM Cognos Analytics 12.0.4 and 12.1.3 versions are affected by security vulnerabilities 27d
Medium CVE-2026-7884 IBM Cognos Analytics versions 12.0.4 and 12.1.3 is affected by security vulnerabilities Sep 14, 2026
Medium CVE-2026-15995 IBM Cognos Analytics 12.1.3 general availability package contains a data integrity issue in the Agentic AI assistant that may cause incorrect report summaries or report-processing errors under concurrent use Jul 17, 2026
High CVE-2025-3633 IBM Cognos Analytics is affected by multiple security vulnerabilities May 27, 2026

Not in any source we poll

Listed rather than left blank: an empty field and an unmeasured one look identical on screen, and only one is a reason to look elsewhere.

No fixed version, patch or mitigation documented.
No confirmed IOCs, IP addresses, domains, file hashes, or malware artifacts supplied.
No organization-specific asset inventory, compensating-control status, or patch deployment evidence supplied.
No exploit packet captures, log samples, or incident case IDs supplied.

Answered from this record

Text assembled only from the fields above — no additional claims.

What should defenders know first?

CVE-2025-36126 is "IBM Cognos Analytics is affected by Cross-site scripting.", rated High. It affects Cognos Analytics (Ibm); versions are in the scope table. It is not in CISA KEV, which does not rule out exploitation. CVSS 7.6 describes technical severity. EPSS 0.19% estimates the probability of exploitation in 30 days; neither replaces your asset context. First verify whether exposed or business-critical assets run the affected versions, apply vendor fixes or mitigations, and preserve logs for review.

Comments

Moderated technical discussion. Read the community guidelines.

No comments yet.